Related Experiment Video
Updated: Aug 12, 2026
04:58
Collecting And Measuring Wound Exudate Biochemical Mediators In Surgical Wounds
Published on: October 20, 2012
Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases
A Guidat1, M Fleyfel, B Vallet
1Hôpital Claude Huriez, Département d'Anesthésie Réanimation 2, Lille, France. a-guidat@chru-lille.fr
European Journal of Anaesthesiology
|December 24, 2003
Summary
Inflammatory bowel disease significantly increases the need for opioids like sufentanil during major abdominal surgery. This is linked to inflammation-induced hyperalgesia and changes in opioid-binding proteins.
Area of Science:
- Anesthesiology
- Gastroenterology
- Pharmacology
Background:
- Inflammation, a hallmark of inflammatory bowel disease (IBD), is known to promote hyperalgesia.
- Increased levels of alpha1-acid glycoprotein (AGP) during inflammation can enhance opioid binding, potentially increasing opioid requirements.
- The impact of acute IBD on intraoperative opioid needs during major abdominal surgery remains an area requiring further investigation.
Purpose of the Study:
- To investigate the influence of acute inflammatory bowel disease (IBD) on intraoperative opioid requirements during major abdominal surgery.
- To compare opioid (sufentanil) consumption in patients with Crohn's disease and ulcerative colitis versus a control group.
- To explore the relationship between plasma alpha1-acid glycoprotein concentrations, free sufentanil fractions, and opioid requirements in IBD patients.
Main Methods:
- Prospective study involving 17 Crohn's disease patients, 12 ulcerative colitis patients, and 7 controls undergoing major abdominal surgery.
- Sufentanil administration was titrated based on a 20% change in hemodynamic variables from preoperative values.
- Plasma concentrations of alpha1-acid glycoprotein and unbound sufentanil were measured in a subgroup; total plasma clearance of sufentanil was determined.
Main Results:
- Patients with Crohn's disease and ulcerative colitis required significantly higher intraoperative sufentanil doses compared to the control group.
- Total plasma clearance of sufentanil was elevated in IBD patients, despite similar surgery durations and free sufentanil fractions.
- Increased alpha1-acid glycoprotein levels were observed in IBD patients, correlating with higher sufentanil consumption during periods of pain stimulation.
Conclusions:
- Acute inflammatory bowel disease significantly increases intraoperative opioid requirements during major abdominal surgery.
- Elevated alpha1-acid glycoprotein and potentially altered sufentanil clearance contribute to the increased opioid demand in IBD patients.
- Understanding these pharmacokinetic and pharmacodynamic changes is crucial for optimizing pain management in IBD patients undergoing surgery.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
08:07Equine Enteric Glial Culture and Application to the Study of a Neural Inflammatory Mechanism in Equine Colic
Published on: October 4, 2024
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...